$ZOM
Zomedica Corp.

2017 Q4 Form 10-K Financial Statement

#000117184319001229 Filed on February 26, 2019

View on sec.gov

Income Statement

Concept 2017 Q4 2017 Q3 2017 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.370M $1.600M $1.060M
YoY Change -42.44% 158.06% 41.33%
% of Gross Profit
Research & Development $1.170M $465.5K $504.2K
YoY Change 101.72% 13.54% 62.66%
% of Gross Profit
Depreciation & Amortization $20.00K $22.90K $22.78K
YoY Change 100.0% 129.03% 127.82%
% of Gross Profit
Operating Expenses $2.560M $465.5K $504.2K
YoY Change -4.83% -55.24% -52.88%
Operating Profit -$2.086M -$1.591M
YoY Change
Interest Expense $0.00 $10.00K $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$2.560M -$2.081M -$1.588M
YoY Change -5.19% 100.07% 49.85%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$2.560M -$2.081M -$1.588M
YoY Change -5.19% 100.07% 49.85%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$28.61K -$23.41K -$18.26K
COMMON SHARES
Basic Shares Outstanding 88.84M 87.08M
Diluted Shares Outstanding 88.84M 87.08M

Balance Sheet

Concept 2017 Q4 2017 Q3 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.450M $4.560M $2.650M
YoY Change 6.81% 18.13% 53.18%
Cash & Equivalents $3.448M $4.563M $2.650M
Short-Term Investments
Other Short-Term Assets $790.0K $580.0K $620.0K
YoY Change 139.39% 141.67% 313.33%
Inventory
Prepaid Expenses
Receivables $28.27K $30.00K $20.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $4.263M $5.170M $3.290M
YoY Change 19.13% 25.79% 72.25%
LONG-TERM ASSETS
Property, Plant & Equipment $371.2K $390.0K $410.0K
YoY Change 28.41% 34.48% 141.18%
Goodwill
YoY Change
Intangibles $15.14K
YoY Change -15.59%
Long-Term Investments
YoY Change
Other Assets $570.0K $640.0K $680.0K
YoY Change -17.39% -7.25% 6700.0%
Total Long-Term Assets $953.1K $1.350M $1.400M
YoY Change -4.43% 3.85% 180.0%
TOTAL ASSETS
Total Short-Term Assets $4.263M $5.170M $3.290M
Total Long-Term Assets $953.1K $1.350M $1.400M
Total Assets $5.216M $6.520M $4.690M
YoY Change 13.99% 20.52% 94.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $830.0K $380.0K $510.0K
YoY Change 13.7% -19.15% 64.52%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $828.7K $380.0K $510.0K
YoY Change 11.82% -19.15% 64.52%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $828.7K $380.0K $510.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $830.0K $380.0K $510.0K
YoY Change 12.16% -20.83% 64.52%
SHAREHOLDERS EQUITY
Retained Earnings -$15.63M
YoY Change 106.67%
Common Stock $20.01M
YoY Change 96.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.387M $5.832M $3.875M
YoY Change
Total Liabilities & Shareholders Equity $5.216M $6.520M $4.690M
YoY Change 13.99% 20.52% 94.61%

Cashflow Statement

Concept 2017 Q4 2017 Q3 2017 Q2
OPERATING ACTIVITIES
Net Income -$2.560M -$2.081M -$1.588M
YoY Change -5.19% 100.07% 49.85%
Depreciation, Depletion And Amortization $20.00K $22.90K $22.78K
YoY Change 100.0% 129.03% 127.82%
Cash From Operating Activities -$1.980M -$1.443M -$2.112M
YoY Change 33.78% -12.0% 157.56%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K $4.775K $2.398K
YoY Change 0.0% -103.67% -111.99%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$10.00K -$4.775K -$2.398K
YoY Change 0.0% -96.33% -88.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $3.320M $3.250M
YoY Change -14.33%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 880.0K 3.361M 2.997M
YoY Change 2.33% -13.81% 9890.45%
NET CHANGE
Cash From Operating Activities -1.980M -1.443M -2.112M
Cash From Investing Activities -10.00K -4.775K -2.398K
Cash From Financing Activities 880.0K 3.361M 2.997M
Net Change In Cash -1.110M 1.913M 882.8K
YoY Change 76.19% -10.17% -208.98%
FREE CASH FLOW
Cash From Operating Activities -$1.980M -$1.443M -$2.112M
Capital Expenditures -$10.00K $4.775K $2.398K
Free Cash Flow -$1.970M -$1.448M -$2.114M
YoY Change 34.01% -4.11% 164.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2018Q2 dei Entity Public Float
EntityPublicFloat
95000000
CY2018 dei Entity Small Business
EntitySmallBusiness
true
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2376519
CY2018 dei Amendment Flag
AmendmentFlag
false
CY2018 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2018 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018 dei Document Period End Date
DocumentPeriodEndDate
2018-12-31
CY2018 dei Document Type
DocumentType
10-K
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
101121923
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
828737
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
2376519
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
828737
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
53659
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
28272
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
49129
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
138742
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
270405
CY2018 us-gaap Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1
72021
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1240139
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1768526
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
849679
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7288
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7288
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
849679
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2083
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2797
CY2018Q4 us-gaap Assets
Assets
6033519
CY2017Q4 us-gaap Assets
Assets
5215822
CY2018Q4 us-gaap Assets Current
AssetsCurrent
3860958
CY2017Q4 us-gaap Assets Current
AssetsCurrent
4262692
CY2018 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div></div> <div style="display: inline; font-weight: bold;">Basis of preparation</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.25in"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">The accounting policies set out below have been applied consistently in the consolidated financial statements.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-style: italic;">Basis of consolidation</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">These consolidated financial statements include the accounts of the Company and its wholly owned operating subsidiary, Zomedica Pharmaceuticals, Inc.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0">All inter-company accounts and transactions have been eliminated on consolidation.</div></div>
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3448147
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3226680
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1940265
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1507882
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
221467
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2017Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2018 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2017 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
97598898
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
90225869
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
97598898
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
90225869
CY2018Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
4280000
CY2017Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
30410648
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
18244659
CY2018Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
112220
CY2017Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
57370
CY2018Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
CY2017Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
90
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
9060130
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3400560
CY2017Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
21379
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
21379
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15141
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13058
CY2017 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
CY2018Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
2105660
CY2017Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
157920
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
171590
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
89970
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
8947910
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3343190
CY2018Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
112220
CY2017Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
57370
CY2018Q4 us-gaap Deposit Assets
DepositAssets
1596104
CY2017Q4 us-gaap Deposit Assets
DepositAssets
636580
CY2018Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
1257347
CY2017Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
569976
CY2018 us-gaap Depreciation
Depreciation
203684
CY2017 us-gaap Depreciation
Depreciation
89613
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
89613
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
203684
CY2018 us-gaap Depreciation Nonproduction
DepreciationNonproduction
203684
CY2017 us-gaap Depreciation Nonproduction
DepreciationNonproduction
89613
CY2018Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
CY2017Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3441
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6238
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8321
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
21379
CY2018 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
941
CY2018 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-312810
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
236350
CY2017 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
13978
CY2018 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-69382
CY2017 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
CY2018Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-69382
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4521349
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3946270
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16647687
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8065072
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
5604720
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1430420
CY2018 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-850310
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
808260
CY2018 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
53280
CY2017 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-297460
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-4494880
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2177570
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11147528
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7093017
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-16647687
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-8065072
CY2018 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
25387
CY2017 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
9351
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1547782
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
94306
CY2018 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
1832114
CY2017 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
124977
CY2018 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
124230
CY2017 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
205143
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13058
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15141
CY2018 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
5651671
CY2017 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
275131
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6033519
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5215822
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2376519
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
828737
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10258643
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7486220
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-618997
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-171736
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-16579246
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-8084050
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
17820
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
17820
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
CY2018Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
29470
CY2017Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
20021
CY2018 us-gaap Payments For Rent
PaymentsForRent
1269073
CY2017Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
32754
CY2017Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
23822
CY2018Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
58160
CY2018 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
58160
CY2017 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
56576
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
627997
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
171736
CY2018Q4 us-gaap Prepaid Advertising
PrepaidAdvertising
37465
CY2017Q4 us-gaap Prepaid Advertising
PrepaidAdvertising
28122
CY2018Q4 us-gaap Prepaid Insurance
PrepaidInsurance
33372
CY2017Q4 us-gaap Prepaid Insurance
PrepaidInsurance
12934
CY2018Q4 us-gaap Prepaid Rent
PrepaidRent
509380
CY2017Q4 us-gaap Prepaid Rent
PrepaidRent
155220
CY2017Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3250000
CY2017Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3320000
CY2018Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
550000
CY2018Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3452496
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8282496
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6570000
CY2017 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-6726
CY2018 us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
9000
CY2017 us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2034307
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
979522
CY2018 us-gaap Professional Fees
ProfessionalFees
1534977
CY2017 us-gaap Professional Fees
ProfessionalFees
1294044
CY2017 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
171736
CY2018 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
627997
CY2018 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
150403
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
338163
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
509899
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
987493
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
371157
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
717088
CY2018 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10317153
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2751326
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-32273787
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15626100
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8080000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
422004
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.84
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.21
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
10000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.65
CY2017Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.50
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.50
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1815000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
535000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1280000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7975000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
7288
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
849679
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
1.50
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.59
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0081
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
1946000
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
100000
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
400000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
75000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
5000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
1978100
CY2017Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.50
CY2017Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.25
CY2017Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.05
CY2017Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.25
CY2018Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.25
CY2018Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.25
CY2018Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
562996
CY2018Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
154000
CY2018Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
85000
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
979522
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2034307
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
3834401
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
4387085
CY2018Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
176000
CY2018Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
50000
CY2018Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
240000
CY2018Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
325000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
3657000
CY2018Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.25
CY2018Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.25
CY2018Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.25
CY2018Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.25
CY2018Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.25
CY2018Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.75
CY2018Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.25
CY2018Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.25
CY2018Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.50
CY2018Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.50
CY2018Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.75
CY2018Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.50
CY2018Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.75
CY2018Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.50
CY2018Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.50
CY2018Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.50
CY2018Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.50
CY2017Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.50
CY2017Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.75
CY2017Q1 us-gaap Share Price
SharePrice
1.35
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y
CY2017 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
1700000
CY2017Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
43613
CY2017Q4 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
112314
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2303896
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1700000
CY2017Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
7060
CY2017Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
80000
CY2017Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
200000
CY2017Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
220000
CY2017Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
7940
CY2018Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
124000
CY2018Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
100000
CY2018Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
50000
CY2018Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
200000
CY2018Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
175000
CY2018Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
26900
CY2018Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
35000
CY2017Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
45000
CY2017Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
230131
CY2017 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
275131
CY2018 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
5651671
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-style: italic;">Use of estimates</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the period. Actual results could differ from those estimates.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">Areas where significant judgment is involved in making estimates are: the fair values of financial assets and liabilities; the determination of fair value of stock-based compensation; the useful lives and recoverability of property and equipment; deferred income taxes and forecasting future cash flows for assessing the going concern assumption.</div></div></div></div></div></div>
CY2018 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2017 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
93440341
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
87400255
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
93440341
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
87400255
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
93440341
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87400255
CY2018Q4 zom Accounts Payable And Accrued Liabilities Due Greater Than1 Year
AccountsPayableAndAccruedLiabilitiesDueGreaterThan1Year
CY2017Q4 zom Accounts Payable And Accrued Liabilities Due Greater Than1 Year
AccountsPayableAndAccruedLiabilitiesDueGreaterThan1Year
CY2018Q4 zom Accounts Payable And Accrued Liabilities Due In3 To6 Months
AccountsPayableAndAccruedLiabilitiesDueIn3To6Months
CY2017Q4 zom Accounts Payable And Accrued Liabilities Due In3 To6 Months
AccountsPayableAndAccruedLiabilitiesDueIn3To6Months
CY2018Q4 zom Accounts Payable And Accrued Liabilities Due In6 To9 Months
AccountsPayableAndAccruedLiabilitiesDueIn6To9Months
CY2017Q4 zom Accounts Payable And Accrued Liabilities Due In6 To9 Months
AccountsPayableAndAccruedLiabilitiesDueIn6To9Months
CY2018Q4 zom Accounts Payable And Accrued Liabilities Due In9 To12 Months
AccountsPayableAndAccruedLiabilitiesDueIn9To12Months
CY2017Q4 zom Accounts Payable And Accrued Liabilities Due In9 To12 Months
AccountsPayableAndAccruedLiabilitiesDueIn9To12Months
CY2018Q4 zom Accounts Payable And Accrued Liabilities Due Less Than3 Months
AccountsPayableAndAccruedLiabilitiesDueLessThan3Months
2376519
CY2017Q4 zom Accounts Payable And Accrued Liabilities Due Less Than3 Months
AccountsPayableAndAccruedLiabilitiesDueLessThan3Months
828737
CY2018Q4 zom Contractual Financial Liabilities
ContractualFinancialLiabilities
2376519
CY2017Q4 zom Contractual Financial Liabilities
ContractualFinancialLiabilities
828737
CY2018Q4 zom Contractual Financial Liabilities Maturity3 To6 Months
ContractualFinancialLiabilitiesMaturity3To6Months
CY2017Q4 zom Contractual Financial Liabilities Maturity3 To6 Months
ContractualFinancialLiabilitiesMaturity3To6Months
CY2018Q4 zom Contractual Financial Liabilities Maturity6 To9 Months
ContractualFinancialLiabilitiesMaturity6To9Months
CY2017Q4 zom Contractual Financial Liabilities Maturity6 To9 Months
ContractualFinancialLiabilitiesMaturity6To9Months
CY2018Q4 zom Contractual Financial Liabilities Maturity9 To12 Months
ContractualFinancialLiabilitiesMaturity9To12Months
CY2017Q4 zom Contractual Financial Liabilities Maturity9 To12 Months
ContractualFinancialLiabilitiesMaturity9To12Months
CY2018Q4 zom Contractual Financial Liabilities Maturity Greater Than1 Year
ContractualFinancialLiabilitiesMaturityGreaterThan1Year
CY2017Q4 zom Contractual Financial Liabilities Maturity Greater Than1 Year
ContractualFinancialLiabilitiesMaturityGreaterThan1Year
CY2018Q4 zom Contractual Financial Liabilities Maturity Less Than3 Months
ContractualFinancialLiabilitiesMaturityLessThan3Months
2376519
CY2017Q4 zom Contractual Financial Liabilities Maturity Less Than3 Months
ContractualFinancialLiabilitiesMaturityLessThan3Months
828737
CY2018Q4 zom Deferred Tax Assets Investment Tax Credit
DeferredTaxAssetsInvestmentTaxCredit
192760
CY2017Q4 zom Deferred Tax Assets Investment Tax Credit
DeferredTaxAssetsInvestmentTaxCredit
87200
CY2018Q4 zom Deferred Tax Assets Schedule13 Reserves
DeferredTaxAssetsSchedule13Reserves
18650
CY2017Q4 zom Deferred Tax Assets Schedule13 Reserves
DeferredTaxAssetsSchedule13Reserves
14030
CY2018Q4 zom Due To Related Parties3 To6 Months
DueToRelatedParties3To6Months
CY2017Q4 zom Due To Related Parties3 To6 Months
DueToRelatedParties3To6Months
CY2018Q4 zom Due To Related Parties6 To9 Months
DueToRelatedParties6To9Months
CY2017Q4 zom Due To Related Parties6 To9 Months
DueToRelatedParties6To9Months
CY2018Q4 zom Due To Related Parties9 To12 Months
DueToRelatedParties9To12Months
CY2017Q4 zom Due To Related Parties9 To12 Months
DueToRelatedParties9To12Months
CY2018Q4 zom Due To Related Parties Greater Than1 Year
DueToRelatedPartiesGreaterThan1Year
CY2017Q4 zom Due To Related Parties Greater Than1 Year
DueToRelatedPartiesGreaterThan1Year
CY2018Q4 zom Due To Related Parties Less Than3 Months
DueToRelatedPartiesLessThan3Months
CY2017Q4 zom Due To Related Parties Less Than3 Months
DueToRelatedPartiesLessThan3Months
CY2018 zom Effective Income Tax Rate Reconciliation Combined Federal And Provincial Statutory Income Tax Rate Percent
EffectiveIncomeTaxRateReconciliationCombinedFederalAndProvincialStatutoryIncomeTaxRatePercent
0.27
CY2017 zom Effective Income Tax Rate Reconciliation Combined Federal And Provincial Statutory Income Tax Rate Percent
EffectiveIncomeTaxRateReconciliationCombinedFederalAndProvincialStatutoryIncomeTaxRatePercent
0.27
CY2017Q1 zom Gain Loss On Settlement Of Liabilities
GainLossOnSettlementOfLiabilities
5000
CY2017 zom Gain Loss On Settlement Of Liabilities
GainLossOnSettlementOfLiabilities
5000
CY2017Q4 zom License And Supply Agreement Contingent On Achievement Of Future Milestone First Payment Cash Portion
LicenseAndSupplyAgreementContingentOnAchievementOfFutureMilestoneFirstPaymentCashPortion
250000
CY2017Q4 zom License And Supply Agreement Contingent On Achievement Of Future Milestone First Payment Equity Portion
LicenseAndSupplyAgreementContingentOnAchievementOfFutureMilestoneFirstPaymentEquityPortion
250000
CY2017Q4 zom License And Supply Agreement Contingent On Achievement Of Future Milestone Second Payment Cash Portion
LicenseAndSupplyAgreementContingentOnAchievementOfFutureMilestoneSecondPaymentCashPortion
250000
CY2017Q4 zom License And Supply Agreement Contingent On Achievement Of Future Milestone Second Payment Equity Portion
LicenseAndSupplyAgreementContingentOnAchievementOfFutureMilestoneSecondPaymentEquityPortion
250000
CY2018Q4 zom Prepaid Expenses And Deposits
PrepaidExpensesAndDeposits
3309449
CY2017Q4 zom Prepaid Expenses And Deposits
PrepaidExpensesAndDeposits
1353105
CY2018Q4 zom Prepaid Expenses And Deposits Current
PrepaidExpensesAndDepositsCurrent
1867034
CY2017Q4 zom Prepaid Expenses And Deposits Current
PrepaidExpensesAndDepositsCurrent
786273
CY2018Q4 zom Prepaid Expenses And Deposits Noncurrent
PrepaidExpensesAndDepositsNoncurrent
1442415
CY2017Q4 zom Prepaid Expenses And Deposits Noncurrent
PrepaidExpensesAndDepositsNoncurrent
566832
CY2018Q4 zom Prepaid Rent Current And Noncurrent
PrepaidRentCurrentAndNoncurrent
1613038
CY2017Q4 zom Prepaid Rent Current And Noncurrent
PrepaidRentCurrentAndNoncurrent
655448
CY2017Q1 zom Settlement Of Liabilities Amout
SettlementOfLiabilitiesAmout
50000
CY2017Q1 zom Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Forfeiture Rate
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate
CY2017Q2 zom Stock Issued During Period Shares Issued For Financing Net Of Cost
StockIssuedDuringPeriodSharesIssuedForFinancingNetOfCost
2902682
CY2017Q3 zom Stock Issued During Period Shares Issued For Financing Net Of Cost
StockIssuedDuringPeriodSharesIssuedForFinancingNetOfCost
1502691
CY2017 zom Stock Issued During Period Value Issued For Financing Net Of Cost
StockIssuedDuringPeriodValueIssuedForFinancingNetOfCost
6513424
CY2018 zom Stock Issued During Period Value Issued For Financing Net Of Cost
StockIssuedDuringPeriodValueIssuedForFinancingNetOfCost
3944336

Files In Submission

Name View Source Status
0001171843-19-001229-index-headers.html Edgar Link pending
0001171843-19-001229-index.html Edgar Link pending
0001171843-19-001229.txt Edgar Link pending
0001171843-19-001229-xbrl.zip Edgar Link pending
exh_1027.htm Edgar Link pending
exh_1028.htm Edgar Link pending
exh_211.htm Edgar Link pending
exh_231.htm Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
f10k_022619p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
logo.jpg Edgar Link pending
mnp.jpg Edgar Link pending
mnp_footer.jpg Edgar Link pending
p12.jpg Edgar Link pending
pipeline.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zom-20181231.xml Edgar Link completed
zom-20181231.xsd Edgar Link pending
zom-20181231_cal.xml Edgar Link unprocessable
zom-20181231_def.xml Edgar Link unprocessable
zom-20181231_lab.xml Edgar Link unprocessable
zom-20181231_pre.xml Edgar Link unprocessable